|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan Y, Chen Y, Jia H, Liu J, Ding Y, Wang
H, Hu Y, Ma J, Zhang X and Li S: Patterns of Life Lost to Cancers
with High Risk of Death in China. Int J Environ Res Public Health.
16:2175–2193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng RS, Sun KX, Zhang SW, Zeng HM, Zou
XN, Chen R, Gu XY, Wei WW and He J: Report of cancer epidemiology
in China, 2015. Zhonghua Zhong Liu Za Zhi. 41:19–28. 2019.(In
Chinese). PubMed/NCBI
|
|
4
|
Zhang H, Guo L and Chen J: Rationale for
Lung Adenocarcinoma Prevention and Drug Development Based on
Molecular Biology During Carcinogenesis. OncoTargets Ther.
13:3085–3091. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang X, Wu L, Xu Y, Zhang B, Wu X, Wang Y
and Pang Z: Trends in the incidence rate of lung cancer by
histological type and gender in Sichuan, China, 1995–2015: A
single-center retrospective study. Thorac Cancer. 9:532–541. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dama E, Melocchi V, Mazzarelli F,
Colangelo T, Cuttano R, Di Candia L, Ferretti GM, Taurchini M,
Graziano P and Bianchi F: Non-Coding RNAs as Prognostic Biomarkers:
A miRNA Signature Specific for Aggressive Early-Stage Lung
Adenocarcinomas. Noncoding RNA. 6:482020.PubMed/NCBI
|
|
7
|
Yang W, Qian F, Teng J, Wang H, Manegold
C, Pilz LR, Voigt W, Zhang Y, Ye J, Chen Q, et al Written on behalf
of the AME Thoracic Surgery Collaborative Group, : Community-based
lung cancer screening with low-dose CT in China: Results of the
baseline screening. Lung Cancer. 117:20–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang F, Wu C, Gu H, Zhu M, Xuan Z, Jiang
Y, Chen H, Fu C and Zheng Y: Lung cancer incidence in female rises
significantly in urban sprawl of Shanghai after introduction of
LDCT screening. Lung Cancer. 132:114–118. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
He D, Yu H and Chen Y: Equity in the
distribution of CT and MRI in China: A panel analysis. Int J Equity
Health. 12:39–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siravegna G, Mussolin B, Venesio T,
Marsoni S, Seoane J, Dive C, Papadopoulos N, Kopetz S, Corcoran RB,
Siu LL, et al: How liquid biopsies can change clinical practice in
oncology. Ann Oncol. 30:1580–1590. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sell S: Cancer markers of the 1990s.
Comparison of the new generation of markers defined by monoclonal
antibodies and oncogene probes to prototypic markers. Clin Lab Med.
10:1–37. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
He Y, Lu H and Zhang L: Serum AFP levels
in patients suffering from 47 different types of cancers and
noncancer diseases. Prog Mol Biol Transl Sci. 162:199–212. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beauchemin N and Arabzadeh A:
Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs)
in cancer progression and metastasis. Cancer Metastasis Rev.
32:643–671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grunnet M and Sorensen JB:
Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung
Cancer. 76:138–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lei L, Chen Q, Wang Z, Han N, Chen B, Qin
J and Lu HY: Usefulness of carcinoembryonic antigen in the
diagnosis of small cell lung cancer combined with adenocarcinoma.
Adv Clin Exp Med. 26:1091–1094. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nakamura H and Nishimura T: History,
molecular features, and clinical importance of conventional serum
biomarkers in lung cancer. Surg Today. 47:1037–1059. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Xu Y and Zhang L: Serum CA153 as
biomarker for cancer and noncancer diseases. Prog Mol Biol Transl
Sci. 162:265–276. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Buccheri G and Ferrigno D: Lung tumor
markers of cytokeratin origin: An overview. Lung Cancer. 34 (Suppl
2):S65–S69. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Uenishi T, Kubo S, Hirohashi K, Tanaka H,
Shuto T, Yamamoto T and Nishiguchi S: Cytokeratin-19 fragments in
serum (CYFRA 21-1) as a marker in primary liver cancer. Br J
Cancer. 88:1894–1899. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Narita T, Funahashi H, Imai T, Takagi H
and Kannagi R: Cytosol and serum concentration of cytokeratin
subunit-19 fragment (cyfra-21-1) in breast-cancer. Oncol Rep.
1:747–750. 1994.PubMed/NCBI
|
|
21
|
Kammer MN, Kussrow AK, Webster RL, Chen H,
Hoeksema M, Christenson R, Massion PP and Bornhop DJ: Compensated
Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung
Cancer. ACS Comb Sci. 21:465–472. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang G, Xiao Z, Tang C, Deng Y, Huang H
and He Z: Recent advances in biosensor for detection of lung cancer
biomarkers. Biosens Bioelectron. 141:1114162019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gu Y, Liu S, Zhang X, Chen G, Liang H, Yu
M, Liao Z, Zhou Y, Zhang CY, Wang T, et al: Oncogenic miR-19a and
miR-19b co-regulate tumor suppressor MTUS1 to promote cell
proliferation and migration in lung cancer. Protein Cell.
8:455–466. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan L, Bing Z, Yan P, Li R, Wang C, Sun
X, Yang J, Shi X, Zhang Y and Yang K: Integrative data mining and
meta-analysis to investigate the prognostic role of microRNA-200
family in various human malignant neoplasms: A consideration on
heterogeneity. Gene. 716:144025. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai B, Kong D-L, Tian J, Liu T-W, Zhou H
and Wang ZF: microRNA-1205 promotes cell growth by targeting APC2
in lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1125–1133.
2019.PubMed/NCBI
|
|
26
|
Wang SS, Fang YY, Huang JC, Liang YY, Guo
YN, Pan LJ and Chen G: Clinical value of microRNA-198-5p
downregulation in lung adenocarcinoma and its potential pathways.
Oncol Lett. 18:2939–2954. 2019.PubMed/NCBI
|
|
27
|
Sheu-Gruttadauria J, Pawlica P, Klum SM,
Wang S, Yario TA, Schirle Oakdale NT, Steitz JA and MacRae IJ:
Structural Basis for Target-Directed MicroRNA Degradation. Mol
Cell. 75:1243–1255.e7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Barile L and Vassalli G: Exosomes: Therapy
delivery tools and biomarkers of diseases. Pharmacol Ther.
174:63–78. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kowal EJK, Ter-Ovanesyan D, Regev A and
Church GM: Extracellular Vesicle Isolation and Analysis by Western
Blotting. Methods Mol Biol. 1660:143–152. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shan B, Ai Z, Zeng S, Song Y, Song J, Zeng
Q, Liao Z, Wang T, Huang C and Su D: Gut microbiome-derived lactate
promotes to anxiety-like behaviors through GPR81 receptor-mediated
lipid metabolism pathway. Psychoneuroendocrinology. 117:1046992020.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Su D, Liao Z, Feng B, Wang T, Shan B, Zeng
Q, Song J and Song Y: Pulsatilla chinensis saponins cause liver
injury through interfering ceramide/sphingomyelin balance that
promotes lipid metabolism dysregulation and apoptosis.
Phytomedicine. 76:1532652020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)). Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep.
8:9227–9235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nigita G, Distefano R, Veneziano D, Romano
G, Rahman M, Wang K, Pass H, Croce CM, Acunzo M and Nana-Sinkam P:
Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.
Sci Rep. 8:10222–10229. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Karagkouni D, Paraskevopoulou MD,
Chatzopoulos S, Vlachos IS, Tastsoglou S, Kanellos I, Papadimitriou
D, Kavakiotis I, Maniou S, Skoufos G, et al: DIANA-TarBase v8: A
decade-long collection of experimentally supported miRNA-gene
interactions. Nucleic Acids Res. 46D:D239–D245. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
eLife. 4:e05005–e05042. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Paraskevopoulou MD, Georgakilas G,
Kostoulas N, Vlachos IS, Vergoulis T, Reczko M, Filippidis C,
Dalamagas T and Hatzigeorgiou AG: DIANA-microT web server v5.0:
Service integration into miRNA functional analysis workflows.
Nucleic Acids Res. 41W:W169–W173. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A Portal for Facilitating Tumor Subgroup Gene
Expression and Survival Analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Warde-Farley D, Donaldson SL, Comes O,
Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT,
et al: The GeneMANIA prediction server: Biological network
integration for gene prioritization and predicting gene function.
Nucleic Acids Res. 38 (Suppl 2):W214–W220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hong QY, Wu GM, Qian GS, Hu CP, Zhou JY,
Chen LA, Li WM, Li SY, Wang K, Wang Q, et al Lung Cancer Group of
Chinese Thoracic Society; Chinese Alliance Against Lung Cancer, :
Prevention and management of lung cancer in China. Cancer. 121
(Suppl 17):3080–3088. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jiang ZF, Wang M and Xu JL: Thymidine
kinase 1 combined with CEA, CYFRA21-1 and NSE improved its
diagnostic value for lung cancer. Life Sci. 194:1–6. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Isgrò MA, Bottoni P and Scatena R:
Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical
Aspects. Adv Exp Med Biol. 867:125–143. 2015. View Article : Google Scholar
|
|
43
|
Papagiannakopoulos T, Bauer MR, Davidson
SM, Heimann M, Subbaraj L, Bhutkar A, Bartlebaugh J, Vander Heiden
MG and Jacks T: Circadian Rhythm Disruption Promotes Lung
Tumorigenesis. Cell Metab. 24:324–331. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Schier AC and Taatjes DJ: Structure and
mechanism of the RNA polymerase II transcription machinery. Genes
Dev. 34:465–488. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huang J, Sun C, Wang S, He Q and Li D:
MicroRNA miR-10b inhibition reduces cell proliferation and promotes
apoptosis in non-small cell lung cancer (NSCLC) cells. Mol Biosyst.
11:2051–2059. 2015. View Article : Google Scholar : PubMed/NCBI
|
